MET409
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MET409, covering 2021-06-01 to 2021-06-01. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]